Cisplatin/imfinzi/etoposide - a chemoimmunotherapy regimen containing cisplatin, durvalumab and etoposide that can be used for the first-line treatment of extensive-stage small cell lung cancer (es-sclc).
Latest articles Cisplatin/imfinzi/etoposide
|This medical article is a stub. You can help WikiMD by expanding it.|
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Cisplatin/imfinzi/etoposide for any updates.